Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-12-06
DOI
10.3389/fphar.2021.770631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors
- (2021) Alan H. Baik et al. CLINICAL SCIENCE
- JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis
- (2021) Rita A. Moura et al. Frontiers in Medicine
- Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
- (2020) Arezoo Hosseini et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
- (2020) Nicolas Palaskas et al. Journal of the American Heart Association
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure
- (2020) Sarah Waliany et al. Annual Review of Pharmacology and Toxicology
- Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor–Associated Myocarditis
- (2020) Lili Zhang et al. CIRCULATION
- New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity
- (2020) Arjun Khunger et al. Current Oncology Reports
- JAK-Inhibitors for the Treatment of Rheumatoid Arthritis: A Focus on the Present and an Outlook on the Future
- (2020) Jacopo Angelini et al. Biomolecules
- Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
- (2019) Brian I. Rini et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
- (2019) Paolo Antonio Ascierto et al. NATURE MEDICINE
- Alemtuzumab for Immune-Related Myocarditis Due to PD-1 Therapy
- (2019) Khashayar Esfahani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2018) J B A G Haanen et al. ANNALS OF ONCOLOGY
- Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists
- (2018) Mauro Frigeri et al. CANADIAN JOURNAL OF CARDIOLOGY
- Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells, by Varun Sasidharan Nair and Eyad Elkord (Erratum)
- (2018) IMMUNOLOGY AND CELL BIOLOGY
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac Toxicity in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Carlo G. Tocchetti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
- (2018) Syed S. Mahmood et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Melanoma response to anti-PD-L1 immunotherapy requires JAK1 signaling, but not JAK2
- (2018) Na Luo et al. OncoImmunology
- Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma
- (2018) Tammy Linlin Song et al. BLOOD
- Immune Checkpoint Inhibitor–Associated Myositis
- (2018) Céline Anquetil et al. CIRCULATION
- Reporting of immune checkpoint inhibitor-associated myocarditis
- (2018) Sadeer G Al-Kindi et al. LANCET
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Tofacitinib for the treatment of ulcerative colitis
- (2018) Agnès Fernández-Clotet et al. Expert Review of Clinical Immunology
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Cardio-toxicity of checkpoint inhibitors
- (2018) Oliver J. Müller et al. Journal of Thoracic Disease
- Targeting Immune Checkpoints in Cancer Therapy
- (2017) Suzanne L. Topalian JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Smoldering myocarditis following immune checkpoint blockade
- (2017) Timothy G. Norwood et al. Journal for ImmunoTherapy of Cancer
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
- (2017) I. Puzanov et al. Journal for ImmunoTherapy of Cancer
- Protective mechanisms of berberine against experimental autoimmune myocarditis in a rat model
- (2016) Xuefei Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- (2016) Douglas B. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans
- (2011) HuiJuan Lv et al. JOURNAL OF CLINICAL INVESTIGATION
- Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection
- (2010) Mark E. Flanagan et al. JOURNAL OF MEDICINAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now